FIRST AMENDMENT TO LOAN AGREEMENT AND GUARANTY This First Amendment to Loan Agreement and Guaranty (this "AMENDMENT"), dated as of July 9, 1999, is made by and among OAIC BUSH STREET, LLC, a Delaware limited liability company (the "BORROWER"), SALOMON...Loan Agreement and Guaranty • November 15th, 1999 • Ocwen Asset Investment Corp • Real estate investment trusts • New York
LOAN AGREEMENT and GuarantyLoan Agreement and Guaranty • August 31st, 2022 • Mesoblast LTD • Biological products, (no disgnostic substances) • New York
THIS LOAN AGREEMENT AND GUARANTY is made and dated as of November 19, 2021 and is entered into by and between Mesoblast Limited ACN 109 431 870, an Australian listed public company (“Parent”), Mesoblast UK Limited, a company incorporated in England and Wales with registered number 07596260 whose registered address is 5 New Street Square, London, EC4A 3TW, UK (“Mesoblast UK”), Mesoblast, Inc., a Delaware corporation (“Mesoblast USA”), Mesoblast International Sàrl, a company organized under the laws of Switzerland (“Mesoblast SUI”) and each of Parent’s Subsidiaries that delivers a Joinder Agreement pursuant to Section 7.13 of the Agreement (together with Mesoblast USA and Mesoblast SUI, collectively referred to as the “Borrowers” and each, a “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as “Lender”) and OAKTREE FUND ADMINISTRATION, LLC, a Delaware limited liability company, in its capacit
FIFTH AMENDMENT TO LOAN AGREEMENT AND GUARANTYLoan Agreement and Guaranty • August 29th, 2024 • Mesoblast LTD • Biological products, (no disgnostic substances)
This Fifth Amendment to Loan Agreement and Guaranty (this “Amendment”) is made as of February 29, 2024, by and between Mesoblast Limited ACN 109 431 870, an Australian listed public company (“Parent”), Mesoblast UK Limited, a company incorporated in England and Wales with registered number 07596260 whose registered address is 5 New Street Square, London, EC4A 3TW, UK (“Mesoblast UK” and together with Parent, the “Guarantors”), Mesoblast, Inc., a Delaware corporation (“Mesoblast USA”), Mesoblast International Sàrl, a limited liability company organized under the laws of Switzerland (“Mesoblast SUI”) and each of Parent’s Subsidiaries that delivers a Joinder Agreement pursuant to Section 7.13 of the Agreement (together with Mesoblast USA and Mesoblast SUI, collectively referred to as the “Borrowers” and each, a “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as “Lender”) and OAKTREE FUND ADM
THIRD AMENDMENT TO LOAN AGREEMENT AND GUARANTYLoan Agreement and Guaranty • August 31st, 2023 • Mesoblast LTD • Biological products, (no disgnostic substances)
This Third Amendment to Loan Agreement and Guaranty (this “Amendment”) is made as of May 19, 2023, by and between Mesoblast Limited ACN 109 431 870, an Australian listed public company (“Parent”), Mesoblast UK Limited, a company incorporated in England and Wales with registered number 07596260 whose registered address is 5 New Street Square, London, EC4A 3TW, UK (“Mesoblast UK” and together with Parent, the “Guarantors”), Mesoblast, Inc., a Delaware corporation (“Mesoblast USA”), Mesoblast International Sàrl, a limited liability company organized under the laws of Switzerland (“Mesoblast SUI”) and each of Parent’s Subsidiaries that delivers a Joinder Agreement pursuant to Section 7.13 of the Agreement (together with Mesoblast USA and Mesoblast SUI, collectively referred to as the “Borrowers” and each, a “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as “Lender”) and OAKTREE FUND ADMINIST
US-DOCS\147369310.6 NOW THEREFORE, in consideration of the premises contained herein, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby...Loan Agreement and Guaranty • March 13th, 2024 • ADC Therapeutics SA • Pharmaceutical preparations • New York
FIRST AMENDMENT TO LOAN AGREEMENT AND GUARANTYLoan Agreement and Guaranty • June 11th, 2007 • Lsi Industries Inc • Electric lighting & wiring equipment • Ontario
This First Amendment to Loan Agreement and Guaranty (this “Amendment”) is made as of June 8, 2007 (“Effective Date”) among LSI SACO TECHNOLOGIES INC., a corporation incorporated and existing under the federal laws of Canada (“Borrower”), LSI INDUSTRIES INC., a corporation organized and existing under the laws of the State of Ohio (“Guarantor”) and FIFTH THIRD BANK (“Bank”), an Ohio banking corporation and authorized foreign bank under the Bank Act (Canada).
FIRST AMENDMENT TO LOAN AGREEMENT AND GUARANTYLoan Agreement and Guaranty • August 31st, 2023 • Mesoblast LTD • Biological products, (no disgnostic substances)
This First Amendment to Loan Agreement and Guaranty (this “Amendment”) is made as of December 22, 2022, by and between Mesoblast Limited ACN 109 431 870, an Australian listed public company (“Parent”), Mesoblast UK Limited, a company incorporated in England and Wales with registered number 07596260 whose registered address is 5 New Street Square, London, EC4A 3TW, UK (“Mesoblast UK” and together with Parent, the “Guarantors”), Mesoblast, Inc., a Delaware corporation (“Mesoblast USA”), Mesoblast International Sàrl, a limited liability company organized under the laws of Switzerland (“Mesoblast SUI”) and each of Parent’s Subsidiaries that delivers a Joinder Agreement pursuant to Section 7.13 of the Agreement (together with Mesoblast USA and Mesoblast SUI, collectively referred to as the “Borrowers” and each, a “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as “Lender”) and OAKTREE FUND ADM
ContractLoan Agreement and Guaranty • August 6th, 2024 • ADC Therapeutics SA • Pharmaceutical preparations • New York
FIRST AMENDMENT TO LOAN AGREEMENT AND GUARANTYLoan Agreement and Guaranty • January 19th, 2024 • ADC Therapeutics SA • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT TO LOAN AGREEMENT AND GUARANTY (this “Amendment”) is entered into effective as of January 16, 2024 (the “First Amendment Effective Date”) among ADC THERAPEUTICS SA, a company formed under the laws of Switzerland (the “Borrower”), each of the Borrower’s Subsidiaries party hereto, the Lenders party hereto and Blue Owl Opportunistic Master Fund I, L.P. (formerly known as Owl Rock Opportunistic Master Fund I, L.P.), a New York limited partnership, in its capacity as administrative agent and collateral agent for itself and the Lenders (in such capacity, the “Agent”).
THIRD AMENDMENT TO LOAN AGREEMENT AND GUARANTYLoan Agreement and Guaranty • April 25th, 2006 • Foster Wheeler LTD • Heavy construction other than bldg const - contractors • New York
This THIRD AMENDMENT TO LOAN AGREEMENT AND GUARANTY, dated as of April 19, 2006 (this “Amendment”), in respect of and to the Loan Agreement and Guaranty, dated as of March 24, 2005, among Foster Wheeler LLC, Foster Wheeler USA Corporation, Foster Wheeler North America Corp., Foster Wheeler Energy Corporation and Foster Wheeler Inc., as Borrowers, the Guarantors party thereto, as Guarantors, the Lenders party thereto, as the Lenders, Morgan Stanley & Co. Incorporated, as the Collateral Agent, Wells Fargo Foothill, Inc. as Administrative Agent and Morgan Stanley Senior Funding, Inc., as Documentation Agent, Syndication Agent, Sole Lead Arranger and Sole Lead Bookrunner, as amended by the First Amendment to Loan Agreement and Guaranty dated as of August 4, 2005 and the Second Amendment to Loan Agreement and Guaranty dated as of October 17, 2005 (the “Loan Agreement”). Capitalized terms not otherwise defined herein shall have the same meanings as set forth in the Loan Agreement.
